TWiM explains how ticagrelor alters the membrane of S. aureus and enhances the activity of vancomycin and daptomycin without eliciting cross-resistance, and the development of a novel continuous disinfectant technology that decreases healthcare-associated infections in ICUs by 70%.

Hosts: Vincent Racaniello, Michael Schmidt, and Michele Swanson.

Become a patron of TWiM.

Links for this episode

• Ticagrelor and S. aureus (mBio)
• Novel disinfectant technology (Am J Inf Control)
• UVC-LED to inactivate foodborne pathogens (Appl Envir Micro)
• UV disinfection systems (ACS Photonics)
• High-touch surfaces in specialized patient care area (CDC)
• Take the TWiM Listener survey!

Send your microbiology questions and comments (email or recorded audio) to [email protected]